Japanese Government Procurement
a Aflibercept (genetical recombination) (11.12 mg 0.278 mL/1 vial with blunt filter needle): approx. 880 vials ...
| Procuring Entity | Sapporo city |
|---|---|
| Category |
0004 Medical & Pharmaceutical Products |
Publication Date
Jul 06, 2016
| Deadline | Sep 02, 2016 |
|---|---|
| Summary |
Summary (1) Nature and quantity of the products to be procured: a Aflibercept (genetical recombination) (11.12 mg 0.278 mL/1 vial with blunt filter needle): approx. 880 vials b Infliximab (genetical recombination) (100 mg/1 vial): approx. 790 vials c Lenalidomide hydrate capsule (5 mg * PTP 40 capsules/1 case): approx. 110 cases d Bortezomib (3 mg/1 vial): approx. 290 vials e Etanercept (genetical recombination) (50 mg pen 1 mL * 2 kit/1 case):approx. 630 cases f Bevacizumab (genetical recombination) (100 mg 4 mL/1 vial): approx. 910 vials g Rituximab (genetical recombination) (500 mg 50 mL/1 vial): approx. 220 vials h Golimumab (genetical recombination) (50 mg 0.5 mL/1 vial):approx.290 vials i Palivizumab (genetical recombination) (100 mg /1 vial): approx. 380 vials (2) Time limit for tender: 17:00 on September 2 (Fri), 2016 (3) Contact point for the notice: Management & Planning Section, Management Department, Management Office, Hospital Bureau, Sapporo Municipal Government, Kita 11-jo Nishi 13-chome 1-1, Chuo-ku, Sapporo 060-8604 Japan. TEL 011-726-2211 |
ID 0b8068029be307da
